Risk factors for postherpetic neuralgia in patients with herpes zoster

被引:290
作者
Jung, BF
Johnson, RW
Griffin, DRJ
Dworkin, RH
机构
[1] Univ Rochester, Sch Med & Dent, Rochester, NY 14642 USA
[2] Univ Bristol, Bristol, Avon, England
[3] Bristol Royal Infirm & Gen Hosp, Bristol, Avon, England
[4] GlaxoSmithKline, Harlow, Essex, England
关键词
D O I
10.1212/01.WNL.0000123261.00004.29
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: To identify risk factors for postherpetic neuralgia (PHN) using a validated definition of this chronic neuropathic pain syndrome, to determine combinations of risk factors that identify patients with a high risk of developing PHN, and to examine the characteristics of patients with subacute herpetic neuralgia, that is, pain that persists beyond the acute phase of herpes zoster but that resolves before PHN can be diagnosed. Methods: The authors examined baseline and follow-up data from 965 herpes zoster patients enrolled within 72 hours of rash onset in two clinical trials of famciclovir. Results: Univariate and multivariate analyses indicated that older age, female sex, presence of a prodrome, greater rash severity, and greater acute pain severity made independent contributions to identifying which patients developed PHN. Patients with subacute herpetic neuralgia who did not develop PHN were significantly younger and had less severe acute pain than PHN patients but were significantly more likely to have severe and widespread rash than patients without persisting pain. Conclusions: The independent contributions to the prediction of PHN made by older age, female sex, presence of a prodrome, greater rash severity, and greater acute pain severity suggest that these risk factors reflect different mechanisms that each contribute to the development of PHN. Subacute herpetic neuralgia that does not progress to PHN may reflect peripheral tissue damage and inflammation caused by a particularly severe or widespread rash.
引用
收藏
页码:1545 / 1551
页数:7
相关论文
共 64 条
[1]  
Arani RB, 2001, STAT MED, V20, P2429, DOI 10.1002/sim.851
[2]  
Arias Elizabeth, 2002, Natl Vital Stat Rep, V51, P1
[3]   Afferent large fiber polyneuropathy predicts the development of postherpetic neuralgia [J].
Baron, R ;
Haendler, G ;
Schulte, H .
PAIN, 1997, 73 (02) :231-238
[4]   HYPOTHESES ON THE PATHOGENESIS OF HERPES ZOSTER-ASSOCIATED PAIN [J].
BENNETT, GJ .
ANNALS OF NEUROLOGY, 1994, 35 :S38-S41
[5]   VALACICLOVIR COMPARED WITH ACYCLOVIR FOR IMPROVED THERAPY FOR HERPES-ZOSTER IN IMMUNOCOMPETENT ADULTS [J].
BEUTNER, KR ;
FRIEDMAN, DJ ;
FORSZPANIAK, C ;
ANDERSEN, PL ;
WOOD, MJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (07) :1546-1553
[6]   The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: A randomized, double-blind, placebo-controlled trial [J].
Bowsher, D .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1997, 13 (06) :327-331
[7]   Epidemiology of varicella zoster virus infection in Canada and the United Kingdom [J].
Brisson, M ;
Edmunds, WJ ;
Law, B ;
Gay, NJ ;
Walld, R ;
Brownell, M ;
Roos, L ;
De Serres, G .
EPIDEMIOLOGY AND INFECTION, 2001, 127 (02) :305-314
[9]   Characteristics of patients with herpes zoster on presentation to practitioners in France [J].
Chidiac, C ;
Bruxelle, J ;
Daures, JP ;
Xuan, TH ;
Morel, P ;
Leplège, A ;
El Hasnaoui, A ;
de Labareyre, C .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (01) :62-69
[10]   Risk factors for postherpetic neuralgia [J].
Choo, PW ;
Galil, K ;
Donahue, JG ;
Walker, AM ;
Spiegelman, D ;
Platt, R .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (11) :1217-1224